rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2001-6-22
|
pubmed:abstractText |
Since 1990, the recommended adjuvant therapy for patients with surgically resected node-positive colon cancer has been 5-fluorouracil (5-FU), usually in combination with leucovorin or levamisole. The purpose of this study is to assess the distribution of adjuvant 5-FU treatment in the elderly.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1528-9117
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
7
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
213-8
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:11419029-Age Factors,
pubmed-meshheading:11419029-Aged,
pubmed-meshheading:11419029-Aged, 80 and over,
pubmed-meshheading:11419029-Analysis of Variance,
pubmed-meshheading:11419029-Antimetabolites, Antineoplastic,
pubmed-meshheading:11419029-Chemotherapy, Adjuvant,
pubmed-meshheading:11419029-Colonic Neoplasms,
pubmed-meshheading:11419029-Female,
pubmed-meshheading:11419029-Fluorouracil,
pubmed-meshheading:11419029-Humans,
pubmed-meshheading:11419029-Lymphatic Metastasis,
pubmed-meshheading:11419029-Male,
pubmed-meshheading:11419029-Regression Analysis
|
pubmed:articleTitle |
Variations in the use of adjuvant chemotherapy for node-positive colon cancer in the elderly: a population-based study.
|
pubmed:affiliation |
Division of Epidemiology, Joseph L. Mailman School of Public Health, PH-18-127, 630 West 168th Street, New York, NY 10032, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|